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Abstract: Diabetic Retinopathy is a microvascular complication of diabetes, that can go undetected
and unnoticed until irreversible damage and even blindness has occurred. Effective screening for
diabetic retinopathy has been proven to reduce the risk of sight loss. The National Health Service
(NHS) which provides healthcare for all UK citizens, implemented systematic retinal screening for
diabetic retinopathy in England in 2003, with the aim of identifying and treating all patients with
sight threatening retinopathy. Crucial to this is patients partaking in the programme. Therefore,
increasing screening uptake has been a major focus of the programme. This review explores the
views of people living with diabetes who do not attend retinal screening, their characteristics,
concerns, experiences of retinal screening and their understanding of the risks of diabetic retinopathy.
All studies that satisfied the study inclusion criteria on ‘patients’ non-attendance at retinal screening’,
between 2003 to 2017 were included after extensive database search. A total of 16 studies were
included in the review. Findings showed that socio-economic deprivation was a major risk factor
for non-attendance, about 11.5–13.4% of the screened population had sight threatening retinopathy
(STDR), repeated nonattendance was linked to sight threatening diabetic retinopathy, and that certain
factors, could be barriers or incentives for screening uptake. Some of those factors are modifiable
whilst others are not.
Keywords: diabetic retinopathy; retinal screening; patients’ non-attendance; systematic review
1. Introduction
Diabetic retinopathy (DR) is a sight threatening, microvascular complication of diabetes that
affects the retina. It is the most common complication of diabetes [1] and a leading cause of blindness
amongst working aged adults in the developed world [2–4]. All persons with diabetes are at risk of
developing retinopathy, however, persons living with type 1 diabetes (T1DM) have a higher chance
of getting DR as compared to persons living with type 2 diabetes (T2DM) [5]. The prevalence of DR
is directly linked to that of diabetes. Some studies estimate a DR prevalence of 34.6% [6,7] and find
that it is more common in T1DM as compared to T2DM [7]. The exact mechanism of how prolonged
hyperglycaemia causes retinopathy is still unclear, however studies have shown that prolonged
hyperglycaemia alters retinal perfusion thereby disturbing the normal physiological and homeostatic
state of the retina, in turn causing retinopathy [8]. Based on the presence or absence of abnormal blood
vessels on the retina, it can broadly be classified into:
• Non-proliferative (NPDR)
• Proliferative (PDR) [9]
These can be further sub-classified into mild, moderate and severe retinopathy. Each level of
classification has a different prognosis of vision with worst visual outcome associated with severe
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proliferative retinopathy. Maculopathy, which occurs when there are changes with the macula,
functionally and severely affects vision, but may or may not be present with non-proliferative or
proliferative retinopathy. In recent times, the natural history and factors that influence the development
of DR have been understood a little better due to large trials and landmark studies in the UK and
around Europe, making the management of DR better [10].
After the St. Vincent’s declaration to reduce blindness from diabetes by a third, the United
Kingdom (UK) became the first country in the world to offer systematically organised screening
for DR to all patients diagnosed with diabetes over the age of 12. This screening programme was
implemented in England in 2003 and it reached nationwide coverage in 2008 [11]. The screening
programmes within the four UK nations are overseen by a national programme and run at the
community level by local programmes [12]. In England, screening is overseen by the National Diabetic
Eye Screening Programme (NDESP) [13], in Wales it is the Diabetic Retinopathy Screening Service
for Wales (DRSSW) [14], in Scotland, screening is run by the Scottish Diabetic Retinopathy Screening
(DRS) [15] and in Northern Ireland, it is the Northern Ireland Diabetic Eye Screening Programme
(DESP) [16]. Each of the four nations in the UK have some variations in their screening protocol and
grading, but in general, retinal photographs are taken through a dilated pupil using non-mydriatic
fundus camera. The photographs are then graded by specialist graders and the results/outcomes of the
screening process are sent to hospital eye services if necessary for treatment, or to the patient’s general
practitioner (GP), if no referable retinopathy is present. So, depending on the results, patients are either
recalled for annual screening, invited back for more frequent surveillance or referred on to hospital
eye services [11].
Apart from coordinating screening, the national programmes are also tasked with training,
accreditation and quality assurance of the local programmes. In addition, they ensure the services go
on smoothly and find ways to increase and improve the screening uptake. In England for instance,
annual reports are put together showing number of patients invited, number screened, uptake,
screening outcomes, referrals etc. within different regions. The 2016/2017 Public Health England’s
report on uptake of retinal screening, showed that some areas neither met the acceptable uptake which
is set at 70% by the National screening committee nor the optimal uptake rate (80%) [17].
To find out why some patients do not engage with these programmes despite its well-known and
documented benefits, this review aims to bring together all existing studies on attendance, so that
reasons for non-attendance can be explored.
2. Methods
To effectively answer the research question, a systematic review of all published and un-published
literature on non-attendance at retinal screening was carried out, using the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis (PRISMA) checklist and flow chart for collecting and
reporting data [18]. All studies on patients with type 1 diabetes or type 2 diabetes published after 2003
were included in the review. Prior to 2003 there was no systematic nationwide screening for retinopathy
worldwide. In 2005, European countries made added commitments to the initial declaration in 1989,
to have formal screening for [19]. Therefore, 2003 was chosen as the cut-off for including studies in
this review, so that results from this review will not be affected by low screening uptake due to lack
of an organised screening programme. In addition, all studies on healthcare providers’ perceptions
of screening non-attendance were included, so as to have a better understanding of the reasons for
patients’ non-attendance and also to not severely restrict the scope of the study. There were no
restrictions placed on patients’ characteristics such as age, sex, duration of diabetes, location, ethnicity,
or country of origin. Excluded in this review were: studies carried out before 2003 even if they were
published after 2003, studies that were written in any language other than English, clinical audits,
and studies that sought to look at interventions to increase screening uptake.
A scoping search using Google Scholar was carried out to build up appropriate search terms to
be used for identifying articles for the study. After which, Wiley Online, Web of science, Ebscohost,
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and Science Direct were searched for articles related to patients’ non-attendance and retinal screening.
The following keywords were used: ‘Patients’, ‘non-attendance’ ‘Retinal Screening’ and ‘Barriers to
access’ (see details of the search terms used and their combinations in Appendix A Tables A1 and A2).
Identified papers for inclusion were downloaded and assessed using the McMaster critical
appraisal tool [20] and were scored out of 15 for quantitative studies and out of 16 for qualitative
studies. A score of 10 was used as the cut off mark for the studies, and only studies with 10 or above
were used in the review. A simple table in Excel was designed to extract the same data from all
included studies, such as; study country, participants, study design, methods, main aim and outcome
etc. A general inductive approach to data analysis was done, to allow for thematic analysis of the
data through rigorous and repeated studying of extracted data and transcripts of the included studies,
grouping segments of texts by themes was done until no new theme emerged from the study. Below is
a flow chart showing the study selection process (see Figure 1).
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3. Results
A total of 132 articles were downloaded, 16 of which were included in the review after critically
appraising the articles. Eleven of the included studies were carried out in the United Kingdom and
one each in Ireland, Iceland, The Netherlands, Saudi Arabia and United States of America. Eight of
the included studies were quantitative studies and 8 qualitative studies. The sample size within each
study varied largely from below 100 to tens of thousands in other studies. The table below summarises
the characteristics of the included studies, their main aims and outcomes.
Five main themes emerged from critically studying the data and the results of the included
studies. The themes were: (1) Demographics of non-attending patients (2) screening invitations;
screening uptake and screening outcome (3) facilitators and barriers to screening compliance
(4) patients’ perceptions and their screening experiences (5) factors that could contribute to better
screening uptake. Below are details of the identified themes (see Table 1).
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Table 1. Showing characteristics of included studies.
Studies Participants N Methods Used Aim Main Outcome
Lake et al. 2017 (UK) [21] Young adults with T2D 30 Structured interviews Explore factors associated withnon-attendance
Some factors such as social influences, etc. are
peculiar to younger adults with T2D.
Al-Alawi et al. 2016 (Saudi Arabia) [22] Hospital staff with diabetes 45 close ended questionnaire Evaluate knowledge, attitudes andbarriers to screening
Most of the participants had excellent knowledge
about diabetic eye complications, absence of gender
specific-professionals was a cause for
non-attendance.
Strutton et al. 2016 (UK)[23] Screening DNAs (≥18 months) 146 Telephone Interview Identify patient and system levelreasons for non-attendance
Patients reasons included, having other
commitments, anxiety etc. and system level reasons
were mostly about miscommunication.
Piling et al. 2015 (UK) [24] Diabetics with learningdisability 71 Retrospective analysis
Find out if there is equality of access
for patients with learning disability
National standards are not met for diabetic patients
with learning disabilities
Hipwell et al. 2014 (UK) [25] Staff and diabetic patients 62 Semi-structuredinterviews
Examine experiences with screening
and how that affects uptake
Knowledge of DR was a major antecedent to
screening, and psychological, pragmatic and social
factors were antecedents to non-attendance.
Lindenmeyer et al. 2014 (UK) [26] GPs 9 GP practices Semi-structuredinterviews
Identify factors that contribute to
screening uptake
Some factors are modifiable such as improving
communication, others were not such as diversity of
ethnicity and languages.
Forster et al. 2013 (UK) [27] Patients first screened in 2008 6556 Retrospective analysis Evaluate whether repeatednon-attendance was linked to STDR Repeated non-attendance increases risk of STDR.
Van Eijk et al. 2012 (The Netherlands) [28] Diabetic patients ≥ 18 years 2363 Focus groups &Questionnaires
Examine barriers and incentives to
screening
81% attendance; non-attenders had lower education
levels, shorter duration of diabetes and were less
likely to use insulin or be checked by and internist.
Waqar et al. 2012 (UK) [29] Screening DNAs (04/09–03/10) 22,651 Retrospective analysis
Evaluate relationships between
socio-economic status and
non-attendance
Increasing non-attendance with deprivation, lowest
DNAs seen in successful professionals and highest
DNAs seen in areas of social housing
Gulliford et al. 2010 (UK) [30] Diabetic patients on a screeningdatabase 59,495 Retrospective analysis
Quantify socio-economic and ethnic
in-equalities in screening
Only a weak association between non-attendance
and deprivation, and smaller than previously
reported inequality in screening.
Leese et al. 2008 (UK) [31] Diabetic patients on a screeningdatabase 15,150 Retrospective analysis
Identify characteristics that
determine attendance status
Socio-economic deprivation increases
non-attendance
Dervan et al. 2008 (Ireland) [32] Patients at diabetic centres 209 Questionnaires
Assess if patients are receiving
regular screening and factors that
influence uptake.
81% of patients had screening done.
Recommendation from a physician was a major
factor in increasing uptake.
Scanlon et al. 2008 (UK) [4] Diabetic patients on a screeningdatabase 10,312 Retrospective analysis
Investigate socio-economic
differences in prevalence of diabetes,
DR and screening uptake
Probability of being screened decreased with
deprivation, prevalence of diabetes and developing
STDR was associated with increasing deprivation
Millet et al. 2006 (UK) [33] Diabetic patients on a screeningdatabase 9750 Retrospective analysis
Assess screening and screening
outcome in South East London
88.9% screening uptake, however, significant
inequity in the delivery of the screening
programme.
Zoega et al. 2005 (Iceland) [34] Patients on the Icelandic blindregistry 22 Retrospective analysis
Find relationship between screening
compliance and visual outcome
Blind patients had worse pre-diagnosis screening
compliance
Hartnett et al. 2005 (USA) [35] Diabetic patients andphysicians at an indigent clinic
2145 records, 17 focus
group participants
Focus group discussions
and interviews
Address inadequate screening and
explore perceived barriers.
Physicians and patients have different perceived
barriers to screening, though they both agreed that
accessing the care was also a barrier
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3.1. Demographics of Non-Attenders
Two of the included studies, [28,31] identified characteristics such as living in socially deprived
areas, being young (age), having poor glycaemic and blood pressure control, smoking, having lower
education, a more recent diagnosis of diabetes and less frequent use of insulin shaped non-attendance
at retinal screening programmes. Socio-economic deprivation was the most referenced demographic
characteristic of non-attenders, with five studies [4,29–33] reporting that non-attendance increased
with higher socio-economic deprivation and that there was a significant and large difference between
the least and most deprived quintile of deprivation in terms of screening attendance using the indices
of English deprivation (IED). The second most referenced characteristic of non-attenders was age,
all the studies that made mention of the age of non-attenders found that non-attendance was highest
amongst younger patients [30–33], and then the much older patients [30], then ethnic minorities,
and being born outside the UK or Republic of Ireland (see Appendix A Figure A1).
3.2. Screening Invitation, Uptake and Outcome
Screening uptake ranged from 61–88.9% amongst the diverse study participants in the individual
studies, however not all eligible patients were invited for screening with only 46% of eligible
patients reported to have been invited in South East London [33]. The percentage of sight threatening
retinopathy identified after screening ranged from 11.5% [30]–60% [34], and that poor visual outcome,
and an increased risk of sight threatening retinopathy were associated with poor compliance and
repeated non-attendance respectively [27,34] (see Appendix A Figure A2).
3.3. Facilitators and Barriers to Screening Compliance
Facilitators for screening were identified as:
i. A recommendation from a healthcare provider [21,25,28,32] and,
ii. Knowledge about effects of non-attendance on vision [21,25,28,32].
Patient level barriers to screening included:
i. Having competing priorities [23],
ii. Anxiety about the screening [23],
iii. Disengagement with diabetes care [23],
iv. Misinformation about screening [23] and,
v. Forgetting to attend for the screening [23].
System level reasons for patients’ non-attendance were:
i. issues about patients’ addresses [23],
ii. not sending the screening invitations out on time [23] and,
iii. patients’ clinical notes not being shared [23].
3.4. Patients’ Perceptions and Experiences of Screening
Misunderstanding the reason for screening and the screening process were noted by a number of
studies [22,25,32,35] Patients gave negative accounts of their experiences of screening and the screening
process. The most cited of which were; lengthy appointment/waiting times, pain discomfort and other
side effects of the drops used to dilate the pupils before the screening and lastly, not being able to be
independent for some time after their pupils have been dilated [25,32].
3.5. Factors that Could Contribute to Better Screening Uptake
Factors such as improving communication between GP practices and screening services,
improving ways in which patients are invited and contacted for the screening, integrating retinal
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screening with other diabetic care, properly educating, inducting and integrating newly diagnosed
diabetic patients into the screening programme, changing the way staff behave towards previous
non-attenders, trying to bridge the language barrier gap, and making the programmes sensitive to
differences of ethnic minorities, and placing screening sites in areas that are easily accessible and have
good transport links [26] can be modified in order to increase screening uptake.
4. Discussion
This review has provided an in-depth understanding on patients’ non-attendance at retinal
screening programmes. The mixture of quantitative and qualitative studies in this review plays a
complementary role in not only identifying the reasons for non-attendance but also explaining them
from not only the healthcare professionals’ views but patients’ also. It is very important to note that
the screening programmes must fully understand their patients, their sensitivities and challenges and
must cater to the needs of the population if the desired outcome is meant to be achieved. For instance,
in the study by Leese et al., in Tayside, Scotland, a sub-urban largely white population, they not only
noted the characteristics of non-attenders, but interestingly they found that travel distance did not
affect attendance, and that attendance was considerably better amongst patients that attended the
static screening services as compared to mobile screening services [31]. This is contrary to findings
from Lindenmeyer et al. that found that transportation and access to the screening site was a factor
that determined screening uptake [26]. This finding could mean that when patients know exactly
where their screening venue is, they are able to plan and make the required commitments to attend the
screening as compared to a screening venue that changes. It could also be that patients did not look
forward to being screened in a van. A qualitative study will be required to fully understand why this
was found.
Secondly, even though there was a relationship between socio-economic deprivation and screening
non-attendance in all the studies that reported the finding, the level of difference identified varied
within the different studies [4,29,30,33]. In Scanlon et al. study, they noted a difference of 9.3% between
the least and most deprived quintiles [4]. In the Millet et al. study however, the difference was much
less with only a 3.8%, between the least and the most deprived quintiles [33]. However, unlike in
the Scanlon et al. study where they considered county wide data for its comparison of uptake and
socio-economic deprivation, Millet et al. used data from only a few South-East London boroughs,
which form some of the most deprived places in England; this could be the reason for the much lower
difference noted in their study because of less disparity in their data to begin with. The study by Waqar
et al. [29], found a difference of 9.4% which is similar to the 9.3% found by Scanlon et al. [4]. However,
when they further classified the ‘do not attend’ (DNAs) patients into first time DNAs (DNA1) and
Repeat DNAs (DNA2), the deprivation analysis showed that there was a difference of 4.9% between
the most and least deprived quintiles among first time non-attenders and a 2.2% difference amongst
repeat non-attenders. These findings are similar to that of Millet et al. [33] and Guilford et al. [30].
Results of the screening uptake were mostly above the optimal level of uptake set by the NDESP,
however generalising the results of screening uptake or inferring that screening uptake is good would
be problematic because the study locations and study population were very different, and the studies
had individual cut-offs for what non-attendance meant. For instance, in the study by Van Ejik et al. [28],
screening uptake was 81%, however non-attendance was defined as not having attended in the past
three years, and accounts of attendance were self-reported through questionnaires that had a 73%
response rate. Whereas in the study by Strutton et al. [23], they defined non-attendance as not having
attended screening in the last 18months. The study by Pilling [26], reported a 65% screening uptake
which was in a very specific population of patients with diabetes and learning disabilities. Ninety-one
percent of the study’s population were offered screening. Which is very different to findings by Millett
and Dodhia [33] where only 46% of the eligible population were invited for screening with 88.9% of
them partaking in the screening programme.
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It is clear that the importance of screening cannot be overemphasized. In the Zoega et al. study,
they compared a group of registered blind patients on the Icelandic register to age matched controls
and found that patients registered as blind had a significantly lower level of pre-diagnosis screening
compliance [34]. Similarly, Forster et al. found that patients who were not screened for two years
before re-attending screening had 10.84 times higher odds of referable retinopathy being detected
when compared to participants who were screened each year [27]. There was no risk of referable
retinopathy for participants who did not attend for screening in one year. They observed the same
pattern for referable maculopathy and STDR though the effect sizes were smaller [27].
Despite the known effects of non-attendance at screening, some patients still do not engage with
these programmes. When looking into barriers and facilitators to screening, most of the studies had
similar findings as mentioned above, except for the study by Hartnett et al. [35] and Al-Alawi et al. [22]
which had unique barriers to screening. Hartnett et al. [35] cited finances as a major barrier to
screening; it is easy to see why that would be a barrier within their study population, because in the
US, healthcare must be paid for at the point of access unlike the UK and most of Europe. The study by
Al-Alawi et al. [22] in Saudi Arabia, also found a barrier to screening that had not been mentioned by
other studies which was a lack of gender specific screening professionals. This finding is an interesting
one as it shows how health seeking behaviour can be influenced by religious and cultural beliefs.
This finding needs to be explored in depth to find ways of improving screening uptake within the
concerned population.
Strengths and Limitations
The rigour and explicit methods of searching for studies, critically appraising the included studies
in order to reduce reporting on studies with a flawed methodology, and thematic analysis to preserve
findings from the primary studies and allow for a more transparent link and comparison are some of
the strengths of this study.
An outcome bias might have been introduced, because non-attendance at screening programmes
was the outcome of choice for this study, therefore only studies reporting on non-attendance were
included in the review and that is a limitation of the study.
5. Conclusions
The current evidence clearly suggests that screening uptake is less than optimal, and identifies
characteristics of non-attendance and reasons for non-attendance. However, there are some limitations
in interpreting the evidence provided, first because there is not a clear definition of non-attendance,
and secondly largely categorising patients into ‘ethnic minority’ or ‘socio-economically deprived’
does little to help our understanding of why the different segments of people within those large
classifications do not attend for retinal screening, e.g., young people. More qualitative research looking
in-depth at which patients do not attend, and seeking to understand why they do not attend, and how
the screening programme can be modified to get them to attend, is needed.
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Appendix
Table A1. Search terms.
Index Term Synonyms Related Terms
Patients non-attendance
(1a) Patients no show
(1b) Patients absenteeism
(1c) do not attend
(1d) non-compliance
(1e) non-concordance
(1f) AWOL
(1g) non- appearance
(1h) Barriers to access
Retinal Screening
(2a) Diabetic eye test
(2b) Diabetic screening
(2c) Diabetic Retinopathy
(2d) retinal monitoring
(2e) Retinal photography
(2f) Retinal checks
(2g) Diabetic maculopathy
motives
(3a) Attitudes
(3b) Reason
(3c) Rationale
(3d) Experiences
(3e) Drive
(3f) Stimulus
(3g) Basis
Table A2. Search strategy.
Date Search Terms Used No. of Papers Excluded No. of Papers Included
Ebscohost
20/3/17
1 [OR] 1a and 2 10 2
1 [OR] 1c and 2 30 7
22/3/17
1c and 2a 2 0
1 and 2b 3 2
1 and 2e 1 0
1c and 2 and 3d 2 1
Web of Science
24/3/17
1 [OR] 1a and 2 1 2
3 [OR] 3d and 2 95 7
Science Direct
27/3/17
3d and 2 2018 6
1c and 2 1908 4
1 and 2 [OR] 2b 124 0
1a [OR] 1c and 2 39,708 2
1a [OR] 1h and 2 2686 9
1a–1h and 2 [OR] 2b 8
Cochrance Library
03/4/17
3d and 2 24 0
3d and 2 1
Nice Database
06/4/17 NICE and 2d 215 35
Scopus
15/06/17
1 [OR] 1c and 2 5 1
3 [OR] 3d and 2 [OR]
2b and 1 7 5
Total: 92
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